PMID- 27604550 OWN - NLM STAT- MEDLINE DCOM- 20171020 LR - 20220330 IS - 1479-5876 (Electronic) IS - 1479-5876 (Linking) VI - 14 IP - 1 DP - 2016 Sep 7 TI - Triglyceride glucose-waist circumference, a novel and effective predictor of diabetes in first-degree relatives of type 2 diabetes patients: cross-sectional and prospective cohort study. PG - 260 LID - 10.1186/s12967-016-1020-8 [doi] LID - 260 AB - BACKGROUND: Body mass index (BMI), waist circumference (WC), visceral adiposity index (VAI), triglyceride glucose index (TyG), TyG-BMI, and TyG-WC have been reported as markers of insulin resistance or type 2 diabetes mellitus (T2DM). However, little is known about the associations between the aforementioned markers and the risk of prediabetes and diabetes in first-degree relatives (FDRs) of T2DM patients. METHODS: 1544 FDRs of T2DM patients (635 men and 909 women) were enrolled in the initial cross-sectional study and all of them finished corresponding examinations. Logistic regression analysis and receiver operating characteristic (ROC) curve were used to compare and identify the associations of the six parameters (BMI, WC, VAI, TyG, TyG-BMI and TyG-WC) with the prevalence of prediabetes and diabetes. Subsequently, 452 of them were followed-up for an average of 5 years. Cox proportional hazard regression model was applied to confirm the predictive value of the optimal marker. RESULTS: Among the indices, TyG-WC was more strongly associated with the prevalence of prediabetes and diabetes. Compared with participants in the lowest quartile of TyG-WC, the adjusted odds ratio and 95 % CIs for prediabetes and diabetes was 11.19 (7.62-16.42) for those in the top quartile of TyG-WC. Moreover, the largest AUC was also observed in TyG-WC (0.765, 95 % CIs 0.741-0.789, P < 0.001). The robust predictive value of TyG-WC was further confirmed in the follow-up study (HR: 7.13, 95 % CIs 3.41-14.90, P < 0.001). CONCLUSIONS: TyG-WC is a novel and clinically effective marker for early identifying the risks of prediabetes and diabetes in FDRs of T2DM patients. FAU - Zheng, Shuang AU - Zheng S AD - Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, No.160 Pujian Road, Shanghai, 200127, China. FAU - Shi, Sheng AU - Shi S AD - Department of Orthopedic Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, No.160 Pujian Road, Shanghai, 200127, China. FAU - Ren, Xingxing AU - Ren X AD - Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, No.160 Pujian Road, Shanghai, 200127, China. FAU - Han, Tingting AU - Han T AD - Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, No.160 Pujian Road, Shanghai, 200127, China. FAU - Li, Yangxue AU - Li Y AD - Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, No.160 Pujian Road, Shanghai, 200127, China. FAU - Chen, Yawen AU - Chen Y AD - Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, No.160 Pujian Road, Shanghai, 200127, China. FAU - Liu, Wei AU - Liu W AD - Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, No.160 Pujian Road, Shanghai, 200127, China. FAU - Hou, Peter C AU - Hou PC AD - Department of Emergency Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. FAU - Hu, Yaomin AU - Hu Y AD - Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, No.160 Pujian Road, Shanghai, 200127, China. amin1031@sina.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160907 PL - England TA - J Transl Med JT - Journal of translational medicine JID - 101190741 RN - 0 (Triglycerides) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Adult MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 2/*diagnosis/*metabolism MH - *Family MH - Female MH - Follow-Up Studies MH - Glucose/*metabolism MH - Humans MH - Male MH - Middle Aged MH - Odds Ratio MH - Prediabetic State/diagnosis MH - Prospective Studies MH - ROC Curve MH - Risk Factors MH - Treatment Outcome MH - Triglycerides/*metabolism MH - *Waist Circumference PMC - PMC5015232 OTO - NOTNLM OT - First-degree relative OT - Triglyceride glucose index OT - TyG-WC OT - Type 2 diabetes mellitus OT - Visceral adiposity index EDAT- 2016/09/09 06:00 MHDA- 2017/10/21 06:00 PMCR- 2016/09/07 CRDT- 2016/09/09 06:00 PHST- 2016/06/15 00:00 [received] PHST- 2016/08/26 00:00 [accepted] PHST- 2016/09/09 06:00 [entrez] PHST- 2016/09/09 06:00 [pubmed] PHST- 2017/10/21 06:00 [medline] PHST- 2016/09/07 00:00 [pmc-release] AID - 10.1186/s12967-016-1020-8 [pii] AID - 1020 [pii] AID - 10.1186/s12967-016-1020-8 [doi] PST - epublish SO - J Transl Med. 2016 Sep 7;14(1):260. doi: 10.1186/s12967-016-1020-8.